Phase II study of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular carcinoma
2015 · Cancer Chemotherapy and Pharmacology · 40 citations
https://doi.org/10.1007/s00280-015-2852-2
A
Andrew Gabrielson
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
175
Papers
2.0K
Citations
21
h-index
37
i10-index
Andrew Gabrielson is an academic researcher from Lurie Children's Hospital. The author has contributed to research in topics: Sexual function and dysfunction studies & Cancer Immunotherapy and Biomarkers & Urological Disorders and Treatments. The author has an h-index of 21, co-authored 149 publications.
ORCID: 0000-0001-9971-9813Papers by this author
worksCollagenase Clostridium Histolyticum in the Treatment of Urologic Disease: Current and Future Impact
2017 · Sexual Medicine Reviews · 39 citations
https://doi.org/10.1016/j.sxmr.2017.03.005
Identification of Lineage-specific Transcriptional Factor–defined Molecular Subtypes in Small Cell Bladder Cancer
2023 · European Urology · 27 citations
https://doi.org/10.1016/j.eururo.2023.05.023
AI-PEDURO – Artificial intelligence in pediatric urology: Protocol for a living scoping review and online repository
2024 · Journal of Pediatric Urology · 13 citations
https://doi.org/10.1016/j.jpurol.2024.10.003
Postoperative Opioid Prescribing in Adolescents and Young Adults After Urologic Procedures Is Associated With New Persistent Opioid Use Disorder: A Large Claims Database Analysis
2023 · Urology · 12 citations
https://doi.org/10.1016/j.urology.2023.08.031
Perioperative opioid prescribing after male fertility procedures is associated with new persistent opioid use: retrospective analysis of a large claims database
2022 · Fertility and Sterility · 11 citations
https://doi.org/10.1016/j.fertnstert.2022.12.015
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat